Skip to main content Accessibility help
×
Home

Quality Standard for Assurance of Measles Immunity Among Health Care Workers

  • Peter J. Krause (a1), Peter A. Gross (a2), Trisha L. Barrett (a3), E. Patchen Dellinger (a4), William J. Martone (a5), John E. McGowan (a6), Richard L. Sweet (a7) and Richard P. Wenzel (a8)...

Abstract

Objective:

The objective of this quality standard is to prevent nosocomial transmission of measles by assuring universal measles-mumps-rubella (MMR) vaccination of all healthcare workers who lack immunity to measles. Although the primary emphasis is on healthcare workers in hospitals, those at other sites, such as clinics, nursing homes, and schools, are also included. It will be the responsibility of designated individuals at these institutions to implement the standard.

Options:

We considered advocating the use of measles vaccine rather than MMR but chose the latter because it also protects against mumps and rubella and because it is more readily available.

Outcomes:

The desired outcome is a reduction in the nosocomial transmission of measles.

Evidence:

Although direct comparative studies are lacking, nosocomial outbreaks of measles have been reported (as recently as 1992) in institutions where measles immunization of nonimmune healthcare workers is not universal, whereas such outbreaks have not been reported in institutions with universal immunization.

Values and Validation:

We consulted more than 50 infectious-disease experts in epidemiology, government, medicine, nursing, obstetrics and gynecology pediatrics, and surgery. In light of disagreement regarding the implementation of the standard, we used group discussions to reach a consensus.

Benefits, Harms, and Cost:

The consequences of the transmission of measles (and of mumps and rubella) in a healthcare institution include not only the morbidity and mortality attributable to the disease, but also the significant cost of evaluating and containing an outbreak and the serious disruption of regular hospital routines when control measures are instituted. The potential harm to healthcare workers after the implementation of the standard consists of untoward effects of MMR vaccine, although the reactions of vaccines should be minimal with adherence to recommended vaccination procedures. Implementation of the standard should entail no expense to healthcare workers; the precise cost to institutions is unknown, but the expense would be mitigated by prevention of measles outbreaks.

Recommendations:

We recommend MMR vaccination of all healthcare workers who lack immunity to measles.

Sponsors:

The Quality Standards Subcommittee of the Clinical Affairs Committee of the Infectious Diseases Society of America (IDSA) developed the standard. The subcommittee was composed of representatives of the IDSA (Drs. Gross and McGowan), the Society for Hospital Epidemiology of America (Dr. Wenzel), the Surgical Infection Society (Dr. Dellinger), the Pediatric Infectious Diseases Society (Dr. Krause), the Centers for Disease Control and Prevention (Dr. Martone), the Obstetrics and Gynecology Infectious Diseases Society (Dr. Sweet), and the Association of Practitioners of Infection Control (Ms. Barrett). Funding was provided by the IDSA and the other cooperating organizations. The standard is endorsed by the IDSA.

Copyright

Corresponding author

Department of Pediatrics, Hartford Hospital, Hartford, CT 06115

References

Hide All
1.Centers for Disease Control. Measles prevention. MMWR 1989:38 (suppl 9): 18.
2.National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, and recommendations. JAMA 1991;266:15471552.
3.Enguidanos, R, Mascola, L, Frederick, P, A survey of hospital infection control policies and employee measles cases during Los Angeles County's measles epidemic, 1987 to 1989. Am J Infect Control 1992;20:301304.
4.Knight, P, Measles epidemic, vaccine shortfall stir up controversy. ASM News 1991;57:560561.
5.Cherry, JD. Measles. In: Feigin, RD, Cherry, JD, eds. Textbook of Pediatric Infectious Diseases. 3rd ed. Philadelnhia. PA: WB Saunders, 1992:15911609.
6.Siegel, M, Fuerst, HTLow birth weight and maternal virus diseases. A prospective study of rubella, measles, mumps, chickenpox. and hepatitis. JAMA 1966;197:680684.
7.Jespersen, CS, Littauer, J, Sagild, U. Measles as a cause of fetal defects:a retrospective study of ten measles epidemics in Greenland. ActaPediatrScand 1977;66:367372.
8.Centers for Disease Control. Rubella prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1990;39(RR-15):118.
9.Centers for Disease Control. Mumps prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1989;38:388400.
10.Arguedas, GA, Deveikis, AA, Marks, MI. Measles. Am J Infect Control 1991;19:290298.
11.Weber, DJ, Rutala, WA, Orenstein, WA. Prevention of mumps, measles, and rubella among hospital personnel. J Pediatr 1991;119:322326.
12.Rivera, ME, Mason, WH, Ross, LA, Wright, HT Jr. Nosocomial measles infection in a pediatric hospital during a community-wide epidemic. J Pediatr 1991;119:183186.
13.Rank, EL, Brettman, L, Katz-Pollack, H, DeHertogh, D, Neville, D. Chronology of a hospital-wide measles outbreak: lessons learned and shared from an extraordinary week in late March 1989. Am /Infect Control 1992;20:315318.
14.U.S. Department of Health and Human Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Boston, MA: Janes and Bartlett Publishers; 1992.
15.Siegel, CS. Measles: a review of the virological and serological methods for early detection. Clin Microbiol Newsletter 1991;13:177179.
16.Houck, P, Scott-Johnson, G, Krebs, L. Measles immunity among community hospital employees. Infect Control Hasp Epidemiol 1991;12:663668.
17.Subbarao, EK, Amin, S, Kumar, ML. Prevaccination serologic screening for measles in health care workers. J Infect Dis 1991;163:876878.
18.Grabowsky, M, Markowitz, L. Serologic screening, mass immunization, and implications for immunization programs. J Infect Dis 1991;164:12371238. Letter.
19.Schwarcz, S, McCaw, B, Fukushima, I? Prevalence of measles susceptibility in hospital staff: evidence to support expanding the recommendations of the Immunization Practices Advisory Committee. Arch Intern Med 1992;152:14811483.
20.Atkinson, WL, Markowite, LE, Adams, NC, Seastrom, GR. Transmission of measles in medical settings-United States, 1985-1989. Am J Med 1991;91(suppl 3B):320S324S.
21.Preblud, SR, Kate, SL. Measles vaccine In: Plotkin, SA, Mortimer, EA, eds. Vaccines. Philadelphia, PA: WB Saunders, 1988:182222.
22.King, GE, Markowitz, LE, Patriarca, PA, Dales, LG. Clinical efficacy of measles vaccine during the 1990 measles epidemic. Pediatr Infect Dis J 1991;10:883888.
23.Krause, PJ, Cherry, JD, Deseda-Tbus, J, et al. Epidemic measles in young adults: clinical, epidemiologic, and serologic studies. Ann Intern Med 1979;90:873876.
24.American Academy of Pediatrics. Report of the Committee on Infectious Diseases. Evanston, IL: American Academy of Pediatrics; 1991.
25.Griffin, MRRay, WA, Mortimer, GM, Fenichel, GM, Schaffner, W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics 1991;88:881885.
26.Chen, RT, Moses, JM, Markowitz, LE, Orenstein, WA. Adverse events following measles-mumps-rubella and measles vaccinations in college students. Vaccine 1991;9:297299.
27.Tingle, AJ, Allen, M, Petty, RE. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunization. Ann Rheum Dis 1986;45:110114.
28.Fasano, MB, Wood, RA, Cooke, SK, Sampson, HA. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine. J Pediatr 1992;120:878881.
29.Hermann, JJ, Radin, R, Schneiderman, RAllergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 1983; 102:196199.
30.Greenberg, MA, Birx, DL. Safe administration of mumps-measles-rubella vaccine in egg-allergic children. J Pediatr 1988; 113:504506.
31.Beck, SA, Williams, LW, Shirrell, MA, Burks, AW. Egg hypersensitivity and measles-mumps-rubella vaccine administration. Pediatrics 1991;88:913917.
32.Kaplan, LJ, Daum, RS, Samron, M, McCarthy, CA. Severe measles in immunocompromised patients. JAMA 1992;267:12371241.
33.Siber, GR, Werner, BG, Halsey, NA, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr 1993;122:204211.
34.Krause, PJ, Cherry, JD, Naiditch, MJ, Deseda-Tous, J, Walbergh, EW: Revaccination of previous recipients of killed measles vaccine; clinical and immunologic studies. J Pediatr 1978;93:565571.
35.Centers for Disease Control. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination. MMWR 1988;37:197200.
36.Gross, PA, Barrett, TL, Dellinger, EP, et al. Consensus develop ment of quality standards. Infect Control Hosp Epidemiol 1994;15:180181.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed